CD36, highly expressed in LN-CAFs, may support lipid metabolism-driven tumor survival in metastatic lymph nodes, whereas COL11A1, elevated in Lung-CAFs, likely enhances ECM remodeling at the primary tumor site. The gene discussed is CD36; the disease is neoplasm.